IFFGD receives support from thousands of individuals located across the United States and in countries outside of the United States. These contributions help us to advance our education, research, and awareness efforts. Individual donations or membership, at any level, supports these efforts. 

We receive corporate support from companies that are involved with the research, development, manufacture, and/or sales of products for the diagnosis, treatment, or management of gastrointestinal disorders or incontinence. The purpose of these contributions is to help fund activities initiated and implemented by IFFGD in order to further our mission.

We have also received support from foundations and from government agencies (National Institutes of Health). These contributions have been in support of education efforts of IFFGD.

Regardless of the source of contributions, IFFGD retains control over the application of funds and over the planning, content, objectives, methods, and execution of all initiatives and projects. We do not endorse specific products, but focus on overall treatment or management issues. IFFGD retains the independence essential to our nonprofit role as an impartial and authoritative resource.

More information about IFFGD activities and financials may be viewed on GuideStar.org, a nonprofit information service.

About IFFGD
Leadership
Nancy J. Norton, IFFGD President
Advisory Board
Board of Directors
Editorial Board Members
Our Mission
Awareness Activities & Accomplishments
Public Education & Awareness
Professional Education & Awareness
Year in Review
-2014
-2012/2013
Advocacy Activities
Legislative Successes
FGIMD Act (Functional Gastrointestinal and Motility Disorders Research Enhancement Act)
Congressional Testimony
FISCAL YEAR 2016
FISCAL YEAR 2013
FISCAL YEAR 2012
FISCAL YEAR 2010
FISCAL YEAR 2009
FISCAL YEAR 2008
FISCAL YEAR 2007
FISCAL YEAR 2006
FISCAL YEAR 2005
FISCAL YEAR 2004
FISCAL YEAR 2003
FDA and Other Testimony
Written Comments to FDA June 29, 2015
Oral Comments to FDA May 11, 2015
Comments to FDA July 16th, 2014
Written Comments to Noridian October 24, 2013
Testimony to FDA October 25, 2012
Testimony to FDA September 12, 2012
Testimony to FDA December 13, 2011
Testimony to FDA December 2, 2010
Testimony to FDA April 23, 2002
Comments to FDA November 9, 2000
Testimony to FDA June 27, 2000
Testimony to FDA June 26, 2000
Capital Hill Advocacy Day
Research
IFFGD Research Awards
IFFGD Symposium reports
2013 Professional Symposium
10th Symposium Report
10th Symposium Audio Recordings
More from the 10th Symposium on FGIDs
2011 Professional Symposium
9th Symposium Report
2009 Professional Symposium
2007 Professional Symposium
7th Symposium Report
2005 Professional Symposium
6th Symposium Report
2003 Professional Symposium
5th Symposium Report
2002 Conference - Advancing the Treatment of Incontinence
Funding
Corporate Support
Our Research Funding Needs
IFFGD Standards for Collaboration
Industry Council
Supporters
Code of Ethics
Contact Us
Media Contact
Donation

Give Today

give today

Your GIFT can change a life

Your donations help to fund life-changing research and education about chronic digestive conditions and the critical need for improved treatments.

Together, we make a difference.

Donate online